Search Results - "Scahill, S L"

Defining pharmacy and its practice: a conceptual model for an international audience by Scahill, S L, Atif, M, Babar, Z U

“…There is much fragmentation and little consensus in the use of descriptors for the different disciplines that make up the pharmacy sector. Globalization,…”
Get full text

What constitutes an effective community pharmacy?—development of a preliminary model of organizational effectiveness through concept mapping with multiple stakeholders by Scahill, S.L., Harrison, J., Carswell, P.

“…Objective To develop a multi-constituent model of organizational effectiveness for community pharmacy. Design Using Concept Systems® software, a project with…”
Get full text

Exploring pharmacists' opinions regarding PHARMAC's interventions in promoting brand changes by Babar, Z.U., Polwin, A., Kan, S.W., Amerasinghe, N., McCarthy, S., Rasheed, F., Stewart, J., Lessing, C., Ragupathy, R., Scahill, S.L.

“…In New Zealand, the use of generic medicines is advocated by the Pharmaceutical Management Agency of New Zealand (PHARMAC). Among other interventions, PHARMAC…”
Get full text

Being healthcare provider and retailer: perceiving and managing tensions in community pharmacy by Scahill, S.L., Tracey, M.S., Sayers, J.G., Warren, L.

“…Background Internationally, pharmaceutical policy has heightened expectations for community pharmacies to act as healthcare professionals, increasing the need…”
Get full text

Interferon- alpha 2a/Ribavirin versus interferon- alpha 2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon by CHAPMAN, Bruce A, STACE, Nigel H, EDGAR, Christine L, BARTLETT, Sharee E, FRAMPTON, Christopher M. A, SCAHILL, Shane L, JENNINGS, Lance C

Get full text

Defining pharmacy and its practice: a conceptual model for an international audience by Scahill, SL, Atif, M, Babar, ZU

“…Background: There is much fragmentation and little consensus in the use of descriptors for the different disciplines that make up the pharmacy sector…”
Get full text

Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon by Chapman, B A, Stace, N H, Edgar, C L, Bartlett, S E, Frampton, C M, Scahill, S L, Jennings, L C

“…To compare the efficacy of a descalating dose of interferon (48 weeks) versus a combination therapy of interferon and ribavirin (24 weeks) in hepatitis C…”
Get full text